Market Tracker

02/27 6:02pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

40.29
Delayed Data
As of Feb 27
 -0.41 / -1.01%
Today’s Change
22.12
Today|||52-Week Range
41.39
+27.18%
Year-to-Date

Today’s Trading

Previous close40.70
Today’s open40.59
Day’s range40.23 - 40.75
Volume661,420
Average volume (3 months)666,912
Market cap$2.9B
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+79.27%
Earnings growth (this year)+56.24%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)-12.07%
P/E ratio27.4
Price/Sales3.29
Price/Book3.47

Competitors

 Today’s
change
Today’s
% change
WXWuxi Pharmatech Caym...-0.59-1.46%
MNKDMannkind Corp-0.30-4.40%
CLVSClovis Oncology Inc-1.43-1.84%
NBIXNeurocrine Bioscienc...-1.00-2.50%
Data as of 4:04pm ET, 02/27/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)$0.15
Annual revenue (last year)$511.5M
Annual profit (last year)$101.3M
Net profit margin19.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Chief Financial Officer &
Senior Vice President
Bryan M. Reasons
Corporate headquarters
Hayward, California

Forecasts